Facilitating Understanding in Informed Consent

Did you read the new draft Guidance from the FDA for Sponsors, Investigators, and IRBs on Key Information and Facilitating Informed Consent?

Did you use plain language principles when developing an informed consent? Watch this webinar as our speaker discusses this guidance.

Upon completion of this continuing education program, participants should be able to:

• Be familiar with changes made to Common Rule and why FDA has issued a new draft guidance.
• Identify Key Information that might impact a trial participant’s decision on whether to participate and approaches to presenting information.
• Learn what FDA recommends on organizing and presenting information to facilitate understanding.

Speaker:

• Brigid Flanagan, BA, RN, MSB, MRQA, Managing Director, Oriel Research Services
  

Approved for 1.0 ACRP Contact Hours | Expires October 9, 2027